-
Gene Therapy SRP-9003 Showing ‘Very Encouraging’ Results at 9 Months in Limb Girdle MD, Sarepta Reports
A 9-month update on three LGMD type 2E childen given one low-dose of the gene therapy SRP-9003 in a clinical trial shows “significant” gains in NSAD scores. Read more here.
What do you think of this study and its findings?
Sorry, there were no replies found.
Log in to reply.